Neurelis
Encinitas
About Neurelis
Neurelis is a specialty pharmaceutical company, licenses, develops, and commercializes product candidates for epilepsy and the broader central nervous system (CNS) market. It provides a differentiated approach to target unmet medical needs. Their application of novel technologies is designed to enhance the therapeutic benefit and patient care. The company was incorporated in 2007 and is based in Encinitas, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $206.1M
- Funding stage: Late Stage Venture
- Last round: Series D (Mar 2021)
- Website: neurelis.com
- Phone: 858-251-2100
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/neurelis-105565 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.